Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines
Today: 27/07/2026 · FUTURE · Forthcoming · Viewed
Funding agency: Horizon Europe
Call: HORIZON-MISS-2027-02
Type of action: HORIZON-PCP HORIZON Pre-commercial Procurement | Deadline model: single-stage | Planned opening: 10/02/2027 | Model Grant Agreement: HORIZON Action Grant Budget-Based
The call supports the implementation of the Cancer Mission through pre-commercial procurement. Proposals should focus on affordable solutions for healthcare systems in the areas of cancer technologies, medical devices, or medicines.
Budget total: 90000000.0 EUR | Budget per project: — EUR
Deadline: 21/09/2027 (421 days left) | Duration: — months | Funding intensity: —% | Type: research
Eligibility: entity types: research and development; countries: EU27 Member States (including prospective Member States), the United Kingdom, Iceland, Liechtenstein, Norway
#cancer#healthcare#medical devices#technologies#medicine
Health
Matching by organization
"Rule filter" means the score came from a hard eligibility/preference check, not the AI — if that reasoning looks wrong for a specific organization, use Override below to correct it by hand; the system's own score stays visible for comparison and is never silently replaced.
| Organization | Match % | Source | Rationale | Override |
|---|---|---|---|---|
| Novatex Solutions LTD | 0% | Rule filter |
Excluded by eligibility/preference filters: Org type 'SME' not among eligible en…Excluded by eligibility/preference filters: Org type 'SME' not among eligible entity types ['research and development']. |
Override |
| European Centre for Emerging Competencies and Technologies | 0% | Rule filter |
Excluded by eligibility/preference filters: Org type 'non-profit' not among elig…Excluded by eligibility/preference filters: Org type 'non-profit' not among eligible entity types ['research and development']. |
Override |